The King Faisal Specialist Hospital & Research Centre (KFSHRC), a leading healthcare provider in Saudi Arabia, is set to make a significant impact on the global healthcare stage. They will be a key partner at the 2024 NYC C3 Summit Davos of Healthcare, a prestigious event taking place in New York City. This year’s summit, held in collaboration with the United Nations General Assembly (UNGA), will be a platform for dialogue and collaboration between the United States and the Arab world on crucial topics in the healthcare sector.
The summit, themed “Tech-Driven Healthcare Evolution & Breakthroughs: Addressing Future Global Challenges & Impact of Advanced Technologies,” will explore the transformative role of technology in healthcare and its potential to address global health challenges. KFSHRC’s presence at the summit reflects its commitment to global collaboration and its dedication to advancing healthcare systems worldwide.
Dr. Björn Zoéga, Deputy Chief Executive Officer of KFSHRC, will kick off the summit with welcoming remarks alongside Professor of Medicine Dr. Ghassan Abou-Alfa, the C3 Summit Co-chair, and Mr. Ransel Potter, the summit’s Founder and Managing Partner. Dr. Zoéga will emphasize the importance of global collaboration in strengthening healthcare systems and building global resilience against future health challenges.
The summit will feature a range of insightful presentations from KFSHRC experts, including:
*
Dr. Feras Khaliel, Head of KFSHRC’s Heart Transplant Program:
Delivering the opening keynote on “The Potential for Technology-Driven Healthcare and Wellness.” This presentation will explore the transformative potential of technology in improving healthcare and promoting well-being.*
Dr. Edward Cupler, Executive Director of Research and Innovation:
Presenting on “A Rising Biotechnology Powerhouse.” This presentation will highlight the advancements in biotechnology and its impact on healthcare innovation.*
Dr. Salah Baz, Executive Director of the Genomics Centre:
Discussing the implementation of genomics in patient care. This presentation will shed light on the revolutionary role of genomics in personalized medicine and disease management.The 2024 C3 Summit will be a significant gathering of healthcare leaders, policymakers, educators, and professionals from the Arab world and the United States. They will engage in discussions on key topics such as future medical center designs, early education for holistic wellness, modern approaches to early cancer detection, and transformative strategies for integrated maternal healthcare.
KFSHRC’s participation in the C3 Summit showcases its commitment to engaging with global healthcare institutions, fostering collaboration, and promoting knowledge exchange through high-profile international conferences. It also underscores KFSHRC’s pioneering experience and reaffirms its dedication to upholding the highest standards of quality and innovation. This aligns with Saudi Vision 2030 and the Health Sector Transformation Program, which aims to transform the healthcare landscape in Saudi Arabia and beyond.
KFSHRC has consistently been recognized for its excellence in healthcare. In 2024, it was ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year. Additionally, it was recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to the 2024 Brand Finance rankings and was ranked among the world’s best 250 hospitals by Newsweek magazine. This prestigious recognition further solidifies KFSHRC’s position as a global leader in healthcare innovation and excellence.
